Ralph Mösges
ORCID: 0000-0002-1928-810X
· 1 paper in corpus
Background: /Objectives: For decades, only native allergen extracts with a high incidence of adverse drug reactions (ADRs) were available for allergen-specific immunotherapy (AIT) - in general administered subcutaneously - to treat allergy…